BCL2L1 and breast carcinoma: The MRE11 signaling pathway is not conserved across different cell types, with our prior report indicating that MRE11 mediates its effects in breast cancer via STAT3 and its downstream effectors cyclin D, Myc, and BCL-xL [11].